2.2. Effect of Supplementation on hs-CRP Levels and other Inflammatory Markers
Considering the primary endpoint hs-CRP, there was an increase from 4.2 ± 2.4 mg/L at W0 to 5.5 ± 3.8 mg/L at W8 in the treatment group (